科研之友
微信
新浪微博
Facebook
分享链接
摘要
Precision medicine is based on accurate diagnosis and tailored intervention through the use of omics and clinical data together with epidemiology and environmental exposures. Precision medicine should be achieved with minimum adverse events and maximum efficacy in patients with chronic kidney disease (CKD). In this review, the breakthroughs of omics in CKD and the application of systems biology are reviewed. The potential role of transforming growth factor-beta(1) in the targeted intervention of renal fibrosis is discussed as an example of how to make precision medicine work for CKD.
- 出版日期2017-3
- 单位东南大学
